Introduction
Benign portal vein (PV) stenosis is a rare complication following hepato-biliary-pancreatic surgery, such as hepatectomy and pancreaticoduodenectomy (PD) (1, 2) . The most frequent cause of stenosis is postoperative inflammation, which leads to portal hypertension and subsequent gastrointestinal hemorrhage from varices (3) . Because a direct surgical approach to the PV is difficult due to adhesions following hepato-biliarypancreatic surgery, PV stent placement is considered a good treatment option for benign PV stenosis (4) .
Here, we report 3 cases of severe PV stenosis following PD treated with portal venous stent placement in a hybrid operating room (OR), which combines a conventional OR with a digital subtraction angiography (DSA) unit (5).
We place this study into appropriate perspective with the most recent clinical practice guidelines.
Patients and Methods

Patients
From August 2016 to July 2017, 62 patients underwent PD, including five hepatopancreatic duodenectomies (HPDs), at the University of Tokyo Hospital. Two patients developed acute PV stenosis with symptoms (patients 1 and 3). Patient 2 was referred from another hospital for surgical resection of remnant pancreatic cancer following PD. In total, 3 patients underwent PV stent placement for severe PV stenosis following PD in a hybrid OR in our hospital from April 2017 to October 2017. Portal vein stent placement was considered when a patient developed symptoms due to portal vein stenosis. However, in patient 2, portal vein stent placement was indicated to avoid complication, such as ascites, related to portal vein stenosis after distal pancreatectomy. Table 1 shows the patient characteristics prior to stent placement. After the surgery, all three patients developed benign PV stenosis at 2, 52, and 3 months. Patient 1 developed melena 6 months after PD, and PV stenosis was identified on computed tomography (CT) scan (Figure 1 preoperative CT scan revealed severe PV stenosis with surrounding soft tissue density area. No malignant cells were found in the soft tissue on repeated endoscopic ultrasound-guided fine needle aspiration (EUS-FNA); thus the PV stenosis might be because of postoperative cholangitis associated with severe stenosis resulting from choledocojejunostomy. Stent placement was performed to relieve stenosis 17 months after PD. Patient 3 developed a liver abscess 2 months after HPD with CT scan revealing PV stenosis. The study was approved by the institutional ethics committee (approval number: CL2017037).
Surgical technique
For our three patients, we used an open trans-ileocecal approach to the portal venous system in a hybrid OR because safe puncture using a percutaneous approach was difficult. In patients 1 and 2, the portal vein diameter of the umbilical portion was small (5 mm) and portal vein flow was difficult to detect. In patient 3, although the portal vein diameter was relatively thick (9 mm), liver abscess existed at the puncture tract. During transileocolic PV stent placement, a midline incision was made on the lower abdomen. A vascular 642 Patients 1 and 3 were symptom free following stent placement for 9 and 3 months, respectively, and patient 2 underwent resection of remnant pancreatic cancer 1 month after stent placement and was complication free for 7 months. The latest stent patency for each patient was confirmed on contrast-enhanced CT at 9, 1, and 5 months following stent placement, respectively. We herein report 3 cases of stent placement for severe benign PV stenosis in a hybrid OR with high-resolution DSA. To our knowledge, this is the first study to report successful PV stent placement owing to the use of hybrid OR.
A hybrid OR combines a conventional OR with an angiography suite, providing radiologists with the same environment as an angiography room outside of the surgical unit. Compared to using a mobile C-arm, better contrast resolution on DSA facilitates optimal balloon inflation and supports accurate stent placement. In the present cases, stent placement using high-resolution DSA images in a hybrid OR contributed to successful stent placements.
In an angiography room, the percutaneous transhepatic approach is ultrasound guided and less invasive but is performed under local anesthesia, and the patient must undergo interventional treatment for 2-3 hours. Additionally, using the retrograde approach to the main PV, the guidewire is sometimes difficult sheath was introduced into the peripheral ileal vein following ileal mesentery dissection. The severity and length of the PV stenosis were examined by highresolution portography using DSA (Figure 2A) . A metallic stent was placed following balloon dilatation of the stenotic site, and additional balloon dilatation of the PV from inside of the stent was performed. Portal pressure gradient was measured before and after stent placement.
Anticoagulant therapy with heparin was administered for 1 week following stent placement and then switched to warfarin (5) for 6 months. Intraoperative and postoperative outcomes are shown in Table 2 .
Results and Discussion
The portal system was clearly visualized in all three patients using DSA in a hybrid OR. The pressure gradient at the stenotic site was 10.5, 21.2, and 9.5 cmH 2 O, respectively. It improved to 3.0, 2.8 and 1.0 cmH 2 O after stent placement. Postoperative courses were uneventful in all patients. The postoperative hospital stay was 11, 7, and 9 days, respectively.
Contrast-enhanced CT scan was performed 1 week after the surgery confirmed PV stent patency. In patient 1, stent patency and collateral vessel shrinkage were detected on contrast-enhanced CT 3 months after stent placement ( Figure 2B, C) . to advance beyond the stenotic site (3). On the other hand, the transileocecal approach requires laparotomy under general anesthesia, but it is possible to advance a guidewire through the thin portal branches, which are difficult to approach using percutaneous transhepatic access. Furthermore, it is easier to place a stent at the stenotic site using an antegrade approach than using a retrograde approach. A hybrid OR is superior to the angiography suite or a regular OR as the approach can be switched immediately whenever necessary. Therefore, referral to a specialized institution with a high-resolution hybrid OR may be beneficial in patients with severe PV stenosis. Benign PV stenosis is a rare complication following hepatobiliary-pancreatic surgery (1, 2) , and is possibly caused by postoperative inflammation, such as pancreatic fistula. In the present cases, the origin of benign PV stenosis was probably due to inflammation after the surgery. Malignancy was ruled out using contrast-enhanced CT, positron emission tomography CT (PET-CT), and biopsy. Patients often develop symptoms of portal hypertension, such as gastrointestinal hemorrhage, ascites, and thrombocytopenia, when PV stenosis is > 80% (6). In our study, stenosis was > 90% in each case, and two of three patients suffered from complications.
Kato et al. (3) performed stent placement in 29 patients using a percutaneous transhepatic approach in 22 patients and using laparotomy via the transileocolic vein in seven patients. In total, 7 patients had stent occlusion: three had acute thrombosis, one had thrombosis at 80 days after stenting, and three had tumor growth. The patency rate was 76%, and the mean stent patency period was 17.3 ± 21.4 months. They also found that presence of a collateral vein is a significant variable related to the development of stent occlusion. Scant evidence supports using anticoagulant therapy following stent placement (7) . In the present cases, warfarin was administered for 6 months after the surgery.
As a major limitation of this study, we did not compare this new approach to previous technique. Future study is necessary to clearly demonstrate the usefulness of a hybrid operating room for this relatively rare situation.
In conclusion, benign PV stenosis is a good indication for PV stent placement. A hybrid OR with high-resolution DSA contributed to the success of PV stent placement.
